Gavi Expanding Sustainable Vaccine Manufacturing in Africa 2022

WHITE PAPER | 2 November 2022

The pandemic has highlighted new and pressing challenges to regional vaccine supply resilience as a critical factor in global health security. While 1.8 billion doses1 of COVID-19 vaccine have been shipped under COVAX, including 0.6 billion to Africa, early delays in obtaining doses on the African continent stimulated new resolve to address future supply security.

Download

View full screen

COVAX: key learnings for future pandemic preparedness and response

WHITE PAPER | 14 September 2022

Drawing on COVAX’s unique experience enabling an unprecedented global rollout at scale during a pandemic, this paper outlines the key challenges the mechanism faced in seeking to ensure equitable access to COVID-19 vaccines, the actions it took in response and recommendations for the future.

Download

View full screen

View page

A New Era of Vaccine Manufacturing in Africa

WHITE PAPER | 22 June 2022

One of the prominent issues exposed by the COVID-19 pandemic is the urgent need to further diversify global vaccine manufacturing, particularly with regards to Africa. With the political realities of nationalism, trade barriers, and the absence of regional manufacturing capability and capacity, rapid and equitable global access to life-saving vaccines can be compromised, leading to delays that put lives at risk.

Download    View in web

View page

Taking stock of humanitarian access to pandemic vaccines

DISCUSSION PAPER | 22 June 2022

COVAX was launched in 2020 with equity as its foundational principle, and fundamental to its design from the outset was a vision to address the most unpredictable and hardest to fill gaps in global COVID-19 vaccine access.

Download    View in web

All Products

16 September 2022

COVAX: key learnings for future pandemic preparedness and response

Drawing on COVAX’s unique experience enabling an unprecedented global rollout at scale during a pandemic, this paper outlines the key challenges the mechanism faced in seeking to ensure equitable access to COVID-19 vaccines, the actions it took in response and recommendations for the future.

25 September 2020

An analysis of sovereign debt and economic risks from COVID-19 in Gavi-supported countries

An analysis of sovereign debt levels in Gavi-supported countries, and the impact of COVID-19 on their economies.

Last updated: 29 Nov 2022

Subscribe to our newsletter